Lyon

• Evaluation of an initial treatment with bevacizumab in combination with chemotherapy and then in combination with niraparib in maintenance i … Recruiting
  2023-504166-37-00 4 2022-02-01 Advanced ovarian, tubal or peritoneal cancer.
• Study evaluating the interest of imatinib treatment maintenance or interruption after at least 10 years of treatment in patients with locall … Recruiting
  2024-512631-77-00 4 2021-12-20 locally advanced or metastatic Gastrointestinal Stromal Tumors
• STUDY TO ASSESS THE SCHEMAS OF RETREATMENT WITH LUTATHERA® IN PATIENTS WITH NEW PROGRESSION OF INTESTINAL WELL-DIFFERENTIATED NEUROENDOCRINE … Recruiting
  2024-511001-28-00 4 2021-12-13 Neuroendocrine tumor
• Short-term Pre-OPerative Durvalumab (MEDI 4736) in early small triple negative breast cancer patients (POP-Durva) Recruiting
  2024-512082-14-00 4 2021-12-06 Untreated small triple negative breast cancer
• DZR123 (CPI-0209) in Patients with Advanced Solid Tumors and Lymphomas Recruiting
  2023-508002-20-00 7 2021-10-21 advanced, solid, relapsed tumors / advanced tumors: human lymphomas /
• Multicentric non-randomized phase II of pembrolizumab in combination with etoposide-cisplatin-based chemotherapy in first-line small cell ov … Recruiting
  2024-515310-40-01 4 2021-08-04 Patients with a confirmed diagnosis of ovarian small cell carcinoma.
• Beamion LUNG-1: A study to test different doses of zongertinib in people with different types of advanced cancer (solid tumours with changes … Recruiting
  2024-511246-39-00 1 2021-07-27 Solid tumours with HER2 aberrations
• Roll Over Study for Patients Who Have Completed a Previous Oncology Study with Olaparib Recruiting
  2024-512982-15-00 5 2021-06-28 BRCA Mutated Ovarian Cancer Patients, Epithelian ovarian cancer, Metas
• IFM2020-05-BENEFIT-Multicenter Open label Phase 3 study of Isatuximab plus Lenalidomide and Dexamethasone with/without Bortezomib in the Tre … Recruiting
  2024-517215-67-00 5 2021-06-11 Newly diagnosed Non-Frail transplant Ineligible Multiple Myeloma elder
• Comparison of Cyclophosphamide and doxorubicin as a first line treatment in elderly patients with metastatic sarcoma Recruiting
  2024-510653-10-00 5 2021-06-04 Advanced or metastatic soft tissue sarcoma (STS) in patients ≥65 years
• Phase 2, Open label Study of Patritumab Deruxtecan (U3-1402), an Anti-HER3-Antibody Drug Conjugate (ADC), in patients with Advanced Breast C … Recruiting
  2023-505923-30-00 4 2021-05-11 Patients with hormone-receptor positive (HR+) and human epidermal grow
• RETINO 2018: conservative treatment for retinoblastoma: efficacy of the new management strategies and visual outcome Recruiting
  2024-514025-30-00 4 2021-03-25 Ocular conservative treatment for retinoblastoma
• A multicenter, prospective, randomized, placebo-controlled, double-blind, multi-arm, multi-stage clinical trial of Ivabradine for heart Rate … Recruiting
  2024-515019-22-00 5 2021-02-26 Septic shock
• Randomized phase III trial on NIraparib-Dostarlimab vs physician’s choice CHEmotherapy in recurrent, ovarian, fallopian tube or primary peri … Recruiting
  2024-516649-38-00 5 2020-12-01 Recurrent ovarian, fallopian tube or primary peritoneal cancer
• RElapse in previously irradiated Prostate bed : a phase I/II study of stereotactic Ablative reIRradiation potentiated by Metformine (REPAIR … Recruiting
  2022-502642-27-00 9 2020-11-26 RElapse in previously irradiated Prostate bed
• GROINSS-V III Recruiting
  2023-508722-99-00 4 2020-11-19 Vulvar cancer
• Study of REGN4018 (Ubamatamab) Administered Alone or in Combination with Cemiplimab in Adult Patients with Recurrent Ovarian Cancer or Other … Recruiting
  2024-510783-23-00 7 2020-10-29 Fallopian Tube Cancer
• Interest of peri operative CHemotherapy In patients with CINSARC highrisk localized Soft Tissue Sarcoma. Recruiting
  2024-515384-62-00 5 2020-10-09 Soft Tissue Sarcoma
• FaR-RMS: An overarching study for children and adults with Frontline and Relapsed RhabdoMyoSarcoma Recruiting
  2024-510579-40-00 9 2020-10-07 Rhabdoyosarcoma
• Clinical trial to evaluate safety and effectiveness of APL-101 for the treatment of advanced MET expressing solid tumors, including Non-Smal … Recruiting
  2024-514542-37-00 9 2020-08-13 Select advanced solid tumors and Non-Small Cell Lung Cancer with MET a
• An international trial for children with atypical teratoid/rhabdoid tumours (ATRT) Recruiting
  2022-501456-28-00 5 2020-07-20 atypical teratoid/rhabdoid tumours (ATRT)
• Randomized phase 3 trial comparing FOLFOX to gemcitabine in metastatic first-line in patients with pancreatic adenocarcinoma and non-fit for … Recruiting
  2024-511904-18-00 10 2020-07-08 Pancreatic adenocarcinoma (PAC)
• Clinical trial evaluating the value of treatment with therapy specifically targeting the molecular alterations identified in the tumor of pa … Recruiting
  2023-510567-35-00 4 2020-06-10 Advanced / metastatic cancers
• Phase 1 study of a Propranolol (HEMANGIOL®) and oral metronomic Vinorelbine (NAVELBINE®) combination on children and teenagers With Refracto … Recruiting
  2024-517185-42-00 3 2020-05-04 Children and teenagers with refractory/relapsing solid tumor

Showing 409–432 of 875 trials